Matches in Wikidata for { <http://www.wikidata.org/entity/Q57149308> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- Q57149308 description "article" @default.
- Q57149308 description "im Oktober 2014 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57149308 description "wetenschappelijk artikel" @default.
- Q57149308 description "наукова стаття, опублікована в жовтні 2014" @default.
- Q57149308 description "հոդված" @default.
- Q57149308 name "Extending the structure-activity relationship of anthranilic acid derivatives as farnesoid X receptor modulators: development of a highly potent partial farnesoid X receptor agonist" @default.
- Q57149308 name "Extending the structure-activity relationship of anthranilic acid derivatives as farnesoid X receptor modulators: development of a highly potent partial farnesoid X receptor agonist" @default.
- Q57149308 type Item @default.
- Q57149308 label "Extending the structure-activity relationship of anthranilic acid derivatives as farnesoid X receptor modulators: development of a highly potent partial farnesoid X receptor agonist" @default.
- Q57149308 label "Extending the structure-activity relationship of anthranilic acid derivatives as farnesoid X receptor modulators: development of a highly potent partial farnesoid X receptor agonist" @default.
- Q57149308 altLabel "Extending the Structure–Activity Relationship of Anthranilic Acid Derivatives As Farnesoid X Receptor Modulators: Development of a Highly Potent Partial Farnesoid X Receptor Agonist" @default.
- Q57149308 altLabel "Extending the Structure–Activity Relationship of Anthranilic Acid Derivatives As Farnesoid X Receptor Modulators: Development of a Highly Potent Partial Farnesoid X Receptor Agonist" @default.
- Q57149308 prefLabel "Extending the structure-activity relationship of anthranilic acid derivatives as farnesoid X receptor modulators: development of a highly potent partial farnesoid X receptor agonist" @default.
- Q57149308 prefLabel "Extending the structure-activity relationship of anthranilic acid derivatives as farnesoid X receptor modulators: development of a highly potent partial farnesoid X receptor agonist" @default.
- Q57149308 P1433 Q57149308-9F176247-57D7-4279-BD08-17F50BEB87C5 @default.
- Q57149308 P1476 Q57149308-7792A632-C5A4-42F1-A562-4DD01916B47D @default.
- Q57149308 P1476 Q57149308-EFAE295C-FD3F-4103-8F46-A1CF0424AEFC @default.
- Q57149308 P2093 Q57149308-48B0D34C-DDBD-4F0D-B256-EF70D06A408B @default.
- Q57149308 P2093 Q57149308-9B39B850-9D15-4A3E-8524-88B2DE039311 @default.
- Q57149308 P2093 Q57149308-BEB8C94D-7D30-4D5D-AE53-48C15C30A6CA @default.
- Q57149308 P2093 Q57149308-EA86D268-F1DA-495C-BC31-59F168608883 @default.
- Q57149308 P304 Q57149308-7000C148-E1E5-4E57-BD46-1B34C5D506E5 @default.
- Q57149308 P304 Q57149308-8CA72FB4-1A1C-45F8-8E37-0F51F001AED3 @default.
- Q57149308 P31 Q57149308-6D2D1580-D28B-4B38-93B4-0ADAF69A5FB5 @default.
- Q57149308 P356 Q57149308-F35D958E-1E82-48A0-9CCE-98F0918595C1 @default.
- Q57149308 P407 Q57149308-9F5C376E-347E-43BE-85C2-0871DB4D7717 @default.
- Q57149308 P433 Q57149308-00C7E5E5-7DDB-4586-9CEF-474E3B799AFB @default.
- Q57149308 P478 Q57149308-EEFDF5DE-16F7-4570-9ADC-E9EDF827AF71 @default.
- Q57149308 P50 Q57149308-1A101C1D-8A7E-4F15-80B5-6675D5F20FD1 @default.
- Q57149308 P50 Q57149308-589DCC79-C7E7-41F8-8D22-AAA1BE1EF506 @default.
- Q57149308 P50 Q57149308-605401EE-A027-4001-889E-BF295BBC139D @default.
- Q57149308 P577 Q57149308-41756622-4020-4EDC-9152-2B85FE5C5AB0 @default.
- Q57149308 P577 Q57149308-E6B59A66-CF78-4AFC-B490-4C62AF9D02F5 @default.
- Q57149308 P698 Q57149308-7CAEB2A8-EF34-48FA-8BDF-A86D82F1D327 @default.
- Q57149308 P356 JM500937V @default.
- Q57149308 P698 25255039 @default.
- Q57149308 P1433 Q900316 @default.
- Q57149308 P1476 "Extending the Structure–Activity Relationship of Anthranilic Acid Derivatives As Farnesoid X Receptor Modulators: Development of a Highly Potent Partial Farnesoid X Receptor Agonist" @default.
- Q57149308 P1476 "Extending the structure-activity relationship of anthranilic acid derivatives as farnesoid X receptor modulators: development of a highly potent partial farnesoid X receptor agonist" @default.
- Q57149308 P2093 "Christina Lamers" @default.
- Q57149308 P2093 "Daniel Merk" @default.
- Q57149308 P2093 "Khalil Ahmad" @default.
- Q57149308 P2093 "Roberto Carrasco Gomez" @default.
- Q57149308 P304 "8035-55" @default.
- Q57149308 P304 "8035-8055" @default.
- Q57149308 P31 Q13442814 @default.
- Q57149308 P356 "10.1021/JM500937V" @default.
- Q57149308 P407 Q1860 @default.
- Q57149308 P433 "19" @default.
- Q57149308 P478 "57" @default.
- Q57149308 P50 Q1222879 @default.
- Q57149308 P50 Q1720710 @default.
- Q57149308 P50 Q51615601 @default.
- Q57149308 P577 "2014-09-25T00:00:00Z" @default.
- Q57149308 P577 "2014-10-09T00:00:00Z" @default.
- Q57149308 P698 "25255039" @default.